Request Demo
Last update 27 Sep 2025
BA-1105
Last update 27 Sep 2025
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms Claudin 18.2 (ADCC) - Shandong Boan Biotechnology, BA 1105, BA-1105 |
Target |
Action inhibitors |
Mechanism CLDN18.2 inhibitors(Claudin 18.2 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects) |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Login to view timeline
Related
1
Clinical Trials associated with BA-1105CTR20220339
在晚期实体瘤患者中评价BA1105注射液安全性、耐受性、药代动力学和初步疗效的Ⅰ期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of BA1105 injection in patients with advanced solid tumors
100 Clinical Results associated with BA-1105
Login to view more data
100 Translational Medicine associated with BA-1105
Login to view more data
100 Patents (Medical) associated with BA-1105
Login to view more data
100 Deals associated with BA-1105
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| CLDN18.2 positive Solid Tumors | Phase 1 | China | 13 Nov 2023 | |
| Advanced gastric carcinoma | Phase 1 | China | 30 Jan 2022 | |
| Gastroesophageal junction adenocarcinoma | Phase 1 | China | 30 Jan 2022 | |
| Pancreatic adenocarcinoma metastatic | Phase 1 | China | 30 Jan 2022 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 17 Jan 2022 | |
| Gastrooesophageal junction cancer | Phase 1 | China | 04 Oct 2021 | |
| Pancreatic Cancer | Phase 1 | China | - | |
| Stomach Cancer | Phase 1 | China | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free